In contrast, monomeric TIAF1 acts synergistically with tumor suppressor p53 and WWOX to counteract cancer growth and migration, whereas both tumor suppressors may have loss-of-function or completely disappeared in metastatic cancer cells [14, 15]. The gene discussed is MYO18A; the disease is metastatic malignant neoplasm.